Pegylated Interferon-α-2a plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Pegylated Interferon-α-2a plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial

Liu, Chen-Hua;Liu, Chun-Jen;Lin, Chih-Lin;Liang, Cheng-Chao;Hsu, Shih-Jer;Yang, Sheng-Shun;Hsu, Ching-Sheng;Tseng, Tai-Chung;Wang, Chia-Chi;Lai, Ming-Yang;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao1, Jia-Horng;
clinical infectious diseases 2008 Vol. 47 pp. 1260-1269
117
chen-hua2008clinicalpegylated

Abstract

Abstract. Background. Comparable sustained virologic response (SVR) rates have been documented between Asian patients who received 24 weeks of pegylated interfe

Keywords

Access

URL:
https://doi.org/10.1086/592579

Citation

ID: 266185
Ref Key: chen-hua2008clinicalpegylated
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
266185
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store